Quick Answer
Arcutis Biotherapeutics, Inc. reported Operating Income of -$12.23 million for fiscal year 2025.
Arcutis Biotherapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$12.23M | +90.5% |
| 2024 | -$128.40M | +46.7% |
| 2023 | -$241.10M | +20.1% |
| 2022 | -$301.63M | -46.0% |
| 2021 | -$206.53M | -51.1% |
| 2020 | -$136.65M | -216.8% |
| 2019 | -$43.13M | -118.6% |
| 2018 | -$19.73M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.53M | +121.8% | +158.4% |
| June 30, 2025 | -$14.61M | +70.8% | +40.4% |
| March 31, 2025 | -$24.53M | +22.4% | +37.2% |
| September 30, 2024 | -$39.07M | -5.9% | +22.0% |
| June 30, 2024 | -$50.08M | +25.0% | -58.4% |
| March 31, 2024 | -$31.62M | +58.5% | +14.3% |
| September 30, 2023 | -$36.90M | +64.8% | +44.7% |
| June 30, 2023 | -$66.76M | -1.4% | +12.5% |
- Arcutis Biotherapeutics, Inc. showed an increase of +90.5% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, Arcutis Biotherapeutics, Inc.’s operating income has grown by 38.0% (from -$19.73 million to -$12.23 million).
- The most recent figure is from Arcutis Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: